Moss Adams Wealth Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Moss Adams Wealth Advisors LLC
- $1.1 Trillion
- Q2 2025
A detailed history of Moss Adams Wealth Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Moss Adams Wealth Advisors LLC holds 751 shares of VRTX stock, worth $291,215. This represents 0.03% of its overall portfolio holdings.
Number of Shares
751
Previous 863
12.98%
Holding current value
$291,215
Previous $419 Million
20.09%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,810Shares Held
232MCall Options Held
1.51MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$11.1 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.26 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.64 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.57 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $99.5B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...